Bionicon
1-800-SKIRMISH
Bionicon petitions FDA to allow over the counter sale of Zelanine
October 6, 2007 – After multiple studies
proving the safety and effectiveness of wonder drug Zelanine, Bionicon is petitioning the FDA to fast-track Bionicon’s
application for over the counter (OTC) sales. Zelanine, the number one prescription
medication for treatment of Slow Growth Disorder (SGD), surpasses other
classes of drugs historically used to increase muscle mass in humans and
animals, with none of the side effects.
Professional
athletes, law enforcement officers and military personnel have enjoyed the
benefits of Zelanine as prescribed by their doctors. Now everyone can attain the added
strength that Zelanine provides.
Unlike steroids, Zelanine is derived from all natural sources, using
our patented recombinant genorhythm techonology, and is approved for use in major
athletic competitions from the Tour de France to the Olympics. Initally developed by Bionicon
scientists to treat delayed growth in children in underdeveloped countries,
Zelanine showed promise in other arenas.
The apparent lack of negative effects led to its use in livestock to
increase meat production and in the military to increase troop stamina.
Each dose of Zelanine
contains 10 mg of the active ingredient plus trace amounts of Anti Regenerative Haloxide as a stabilizer.